Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Anderson

Showing results (661-670 of 7,502) with videos related to

Pageof 751
Sort By:
BMC Genetics|October 1, 2005
Epigenetic predisposition to expression of TIMP1 from the human inactive X chromosomeCatherine L Anderson, Carolyn J Brown
Biochemical and Biophysical Research Communications|August 30, 2005
Tocotrienols reverse IKAP and monoamine oxidase deficiencies in familial dysautonomiaSylvia L Anderson, Berish Y Rubin
American Journal of Ophthalmology|May 15, 1992
Treatment of pseudotumor cerebri by primary and secondary optic nerve sheath decompressionR L Anderson, P M Flaharty
The Annals of Pharmacotherapy|May 4, 2004
Continuous subcutaneous infusion of opiates at end-of-lifeStacey L Anderson, Scott T Shreve
Clinics in Plastic Surgery|April 1, 1992
Cosmetic eyelid surgery and the problem eyelidW M McLeish, R L Anderson
Immunology|February 1, 1979
Human-mouse mixed lymphocyte cultures. II. Partial separation of functionally distinct populations on discontinuous albumin gradientsA W Boylston, R L Anderson
Applied Optics|February 13, 2008
Robustness of spatial-coherence multiplexing under receiver misalignmentL J Pelz, B L Anderson
Virology|March 1, 2008
APOBEC3G restricts early HIV-1 replication in the cytoplasm of target cellsJenny L Anderson, Thomas J Hope
The Nurse Practitioner|June 1, 1992
Assessment and treatment strategies for depressive disorders commonly encountered in primary care settingsM V Perry, G L Anderson
Current HIV/AIDS Reports|August 11, 2005
Updated clinical pharmacologic considerations for HIV-1 protease inhibitorsPeter L Anderson, Courtney V Fletcher
Pageof 751

Showing results (661-670 of 7,502) with videos related to

Sort By:
Pageof 751
BMC Genetics|October 1, 2005
Epigenetic predisposition to expression of TIMP1 from the human inactive X chromosomeCatherine L Anderson, Carolyn J Brown
Biochemical and Biophysical Research Communications|August 30, 2005
Tocotrienols reverse IKAP and monoamine oxidase deficiencies in familial dysautonomiaSylvia L Anderson, Berish Y Rubin
American Journal of Ophthalmology|May 15, 1992
Treatment of pseudotumor cerebri by primary and secondary optic nerve sheath decompressionR L Anderson, P M Flaharty
The Annals of Pharmacotherapy|May 4, 2004
Continuous subcutaneous infusion of opiates at end-of-lifeStacey L Anderson, Scott T Shreve
Clinics in Plastic Surgery|April 1, 1992
Cosmetic eyelid surgery and the problem eyelidW M McLeish, R L Anderson
Immunology|February 1, 1979
Human-mouse mixed lymphocyte cultures. II. Partial separation of functionally distinct populations on discontinuous albumin gradientsA W Boylston, R L Anderson
Applied Optics|February 13, 2008
Robustness of spatial-coherence multiplexing under receiver misalignmentL J Pelz, B L Anderson
Virology|March 1, 2008
APOBEC3G restricts early HIV-1 replication in the cytoplasm of target cellsJenny L Anderson, Thomas J Hope
The Nurse Practitioner|June 1, 1992
Assessment and treatment strategies for depressive disorders commonly encountered in primary care settingsM V Perry, G L Anderson
Current HIV/AIDS Reports|August 11, 2005
Updated clinical pharmacologic considerations for HIV-1 protease inhibitorsPeter L Anderson, Courtney V Fletcher
Pageof 751